IP Library Granted Patent US 12,246,159
Granted Patent B2
US 12,246,159 · App. 17/491,949 · Granted Mar 11, 2025

Multi-cartridge fluid delivery device

Inventors: Robert R. Gonnelli (Mahwah, NJ); Steven F. Levesque (North Pembroke, MA); Ronald V. Nardi (Mahwah, NJ)
Assignee: MANNKIND CORPORATION
A61M5/1407A61M5/14526A61M5/1454A61M5/16827A61M5/32A61M5/3298
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,246,159
App. No.
17/491,949
Granted
Mar 11, 2025
Kind
B2
Abstract

A fluid delivery device for administering a first medicament and a second medicament includes a first fluid reservoir configured to contain the first medicament and a second fluid reservoir configured to contain the second medicament. The fluid delivery device may include one or more basal drive mechanisms to provide a basal delivery of one or more of the first and second medicaments. The fluid delivery device may further include one or more bolus drive mechanisms to provide a bolus delivery of one or more of the first and second medicaments.

Claims (30)

1. A method of administering first and second medicaments from a fluid delivery device comprising:

delivering a first basal delivery of a first medicament;

delivering a second basal delivery of a second medicament;

delivering a first bolus delivery of the first medicament; and

delivering a second bolus delivery of the second medicament,

wherein delivering the first basal delivery includes actuating a first basal drive mechanism and delivering the second basal delivery includes actuating the first basal drive mechanism,

wherein delivering the first bolus delivery includes actuating a first bolus drive mechanism and delivering the second bolus delivery includes actuating the first bolus drive mechanism,

wherein the basal delivery is a sustained delivery of medicament and the bolus delivery is a predetermined amount of medicament of medicament delivered over a shorter amount of time than the basal delivery.

2. The method of claim 1 , wherein the fluid delivery device comprises a bolus drive mechanism including a ratchet and a bolus piston coupled to the ratchet for delivering the first bolus delivery and the second bolus delivery.

3. The method of claim 1 , wherein the first basal drive mechanism includes a coil spring, a basal drive piston, and a hydraulic fluid reservoir.

4. The method of claim 3 , further comprising delivering the first basal delivery of the first medicament, and delivering the second basal delivery of the second medicament, at the same time.

5. The fluid delivery device of claim 4 , wherein delivering the first medicament and the second medicament at the same time includes actuating the basal drive piston which is in fluid communication with both a first drive piston configured to exert a force on the first medicament and a second drive piston configured to exert a force on the second medicament.

6. The method of claim 1 , wherein the fluid delivery device comprises a single needle for delivering each of the first and second medicaments.

7. The method of claim 1 , wherein one of the first or second medicaments is insulin or an insulin analog.

8. The method of claim 7 , wherein the other of the first or second medicaments comprises a drug selected to improve performance of, or decrease a side effect profile of, the insulin or insulin analog.

9. A fluid delivery device comprising:

a first medicament;

a second medicament;

a first basal drive mechanism for delivering i) a first basal delivery of the first medicament to a user of the fluid delivery device and ii) a second basal delivery of the second medicament to the user of the fluid delivery device; and

a bolus drive mechanism, including a ratchet and a bolus piston coupled to the ratchet, for delivering i) a first bolus delivery of the first medicament and ii) a second bolus delivery of the second medicament,

wherein the basal delivery is a sustained delivery of medicament and the bolus delivery is a predetermined amount of medicament of medicament delivered over a shorter amount of time than the basal delivery.

10. The fluid delivery device of claim 9 , wherein the first basal drive mechanism includes a coil spring, a basal drive piston, and a hydraulic fluid reservoir.

11. The fluid delivery device of claim 9 , wherein the fluid delivery device further comprises a single needle for delivering each of the first and second medicaments.

12. The fluid delivery device of claim 9 , wherein the fluid delivery device is configured for delivering the first basal delivery of the first medicament, and delivering the second basal delivery of the second medicament, at the same time.

13. The fluid delivery device of claim 9 , wherein one of the first or second medicaments is insulin or an insulin analog.

14. The fluid delivery device of claim 13 , wherein the other of the first or second medicaments comprises a drug selected to improve performance of, or decrease a side effect profile of, the insulin or insulin analog.

15. The fluid delivery device of claim 9 , wherein the fluid delivery device further comprises:

a hydraulic fluid reservoir within the first basal drive mechanism;

a first pump chamber in fluid communication within the hydraulic fluid reservoir of the first basal drive mechanism via a first flow restrictor, the first pump chamber configured provide basal delivery of the first medicament; and

a second pump chamber in fluid communication with the hydraulic fluid reservoir of the first basal drive mechanism via a second flow restrictor, the second pump chamber configured to provide basal delivery of the second medicament.

Assignments (7)
PATENT SECURITY AGREEMENT Recorded Aug 12, 2025
From: MANNKIND CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 072444/0525 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2022
From: ZEALAND PHARMA A/S
To: MANNKIND CORPORATION
Reel/Frame 060984/0295 →
RELEASE OF SECURITY INTEREST Recorded Aug 24, 2022
From: ZOOLANDER SA LLC
To: ZEALAND PHARMA A/S
Reel/Frame 060887/0685 →
CHANGE OF NAME Recorded Nov 29, 2021
From: VALERITAS LLC
To: VALERITAS, INC.
Reel/Frame 058264/0751 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2021
From: BIOVALVE TECHNOLOGIES, INC.
To: VALERITAS, LLC
Reel/Frame 058229/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2021
From: GONNELLI, ROBERT; LEVESQUE, STEVEN F.; NARDI, RONALD V.
To: BIOVALVE TECHNOLOGIES, INC.
Reel/Frame 058229/0618 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2021
From: VALERITAS, INC.
To: ZEALAND PHARMA A/S
Reel/Frame 058230/0530 →